Idiopathic pulmonary fibrosis in a referral center in Iran: are patients developing the disease at a younger age?

Hashemi Sadraei, Neda; Riahi, Taghi; Masjedi, Mohammad Reza

Hashemi Sadraei, Neda; Riahi, Taghi; Masjedi, Mohammad Reza.

Affiliation

Hashemi Sadraei N; Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA. neda.hashemisadraei@uth.tmc.edu

Arch Iran Med ; 16(3): 177-81, 2013 Mar.

Article in En | MEDLINE | ID: mdl-23432171

Subject(s)

Idiopathic Pulmonary Fibrosis/epidemiology; Acetylcysteine/therapeutic use; Adolescent; Adrenal Cortex Hormones/therapeutic use; Adult; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents/therapeutic use; Azathioprine/therapeutic use; Child; Drug Therapy, Combination; Expectorants/therapeutic use; Female; Follow-Up Studies; Humans; Idiopathic Pulmonary Fibrosis/diagnosis; Idiopathic Pulmonary Fibrosis/drug therapy; Idiopathic Pulmonary Fibrosis/mortality; Immunosuppressive Agents/therapeutic use; Iran/epidemiology; Kaplan-Meier Estimate; Male; Middle Aged; Retrospective Studies; Tertiary Care Centers/statistics & numerical data; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Arch Iran Med Year: 2013 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google